Sparton announces contract manufacturing award from Talyst

Sparton Corporation (NYSE: SPA), a supplier of complex and reliable electronic and electro-mechanical products, sub-assemblies and related services to the highly regulated Medical, Defense & Security, and Aerospace markets, announces an initial contract manufacturing award from Talyst, Inc. located in Bellevue, WA.

“Our decision to partner with Sparton was driven by their quality and process capabilities demonstrated by their work on our award winning AutoCool product”

Talyst is a leading provider of pharmacy automation, medication dispensing and medication packaging solutions. Committed to the precise delivery of medications for patients in long-term care facilities and acute care Hospitals, Talyst engineers the safer pharmacy.

"Our decision to partner with Sparton was driven by their quality and process capabilities demonstrated by their work on our award winning AutoCool product," said Carla Corkern, Chief Executive Officer at Talyst. "Talyst truly feels that Sparton plays a significant role in supporting our market leadership and we look forward to our collective success."

Sparton will provide a full system build at its Fredrick, Colorado operation utilizing its internal circuit card assembly capability, contemporary quality tools, and collaborative manufacturing process.

"Partnering and collaborating with our customers to ensure mutual success is one of our corporate values," commented Cary Wood, President& CEO of Sparton Corporation. "This contract win is also a leading indicator that our new business development efforts are beginning to take hold and we are excited with the opportunity that Talyst has given us to be their extended manufacturing arm."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study explores obecabtagene autoleucel for adults with hard-to-treat leukemia